Fidelity International’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $102M | Sell |
447,421
-31,220
| -7% | -$7M | 0.08% | 233 |
|
|
2025
Q4 | $102M | Buy |
478,641
+19,301
| +4% | +$3.99M | 0.08% | 233 |
|
|
2025
Q3 | $91.3M | Sell |
459,340
-4,756
| -1% | -$887K | 0.07% | 239 |
|
|
2025
Q2 | $80.1M | Buy |
464,096
+1,730
| +0.4% | +$282K | 0.07% | 256 |
|
|
2025
Q1 | $72.1M | Sell |
462,366
-266,909
| -37% | -$38.1M | 0.07% | 266 |
|
|
2024
Q4 | $100M | Buy |
729,275
+89,016
| +14% | +$11.7M | 0.09% | 217 |
|
|
2024
Q3 | $95.6M | Buy |
640,259
+197,751
| +45% | +$26.7M | 0.09% | 234 |
|
|
2024
Q2 | $60.3M | Buy |
442,508
+431,781
| +4,025% | +$58.7M | 0.06% | 284 |
|
|
2024
Q1 | $1.62M | Buy |
10,727
+4,729
| +79% | +$675K | ﹤0.01% | 694 |
|
|
2023
Q4 | $755K | Buy |
+5,998
| New | +$598K | ﹤0.01% | 719 |
|
|
2023
Q2 | – | Sell |
-45,000
| Closed | -$4.82M | – | 809 |
|
|
2023
Q1 | $4.82M | Sell |
45,000
-65
| -0.1% | -$7.44K | 0.01% | 573 |
|
|
2022
Q4 | $5.5M | Buy |
+45,065
| New | +$5.23M | 0.01% | 572 |
|
|
2021
Q4 | – | Sell |
-669
| Closed | -$107K | – | 812 |
|
|
2021
Q3 | $107K | Sell |
669
-134,325
| -100% | -$18.4M | ﹤0.01% | 797 |
|
|
2021
Q2 | $17.8M | Sell |
134,994
-36,889
| -21% | -$4.92M | 0.02% | 473 |
|
|
2021
Q1 | $22.2M | Buy |
171,883
+8,359
| +5% | +$1.27M | 0.03% | 425 |
|
|
2020
Q4 | $27.3M | Buy |
163,524
+68,607
| +72% | +$11.3M | 0.03% | 369 |
|
|
2020
Q3 | $14.6M | Buy |
94,917
+124
| +0.1% | +$17.8K | 0.02% | 440 |
|
|
2020
Q2 | $14M | Sell |
94,793
-97,171
| -51% | -$13.3M | 0.02% | 432 |
|
|
2020
Q1 | $21.6M | Buy |
191,964
+22,328
| +13% | +$2.9M | 0.04% | 350 |
|
|
2019
Q4 | $23.6M | Sell |
169,636
-14,967
| -8% | -$1.66M | 0.03% | 377 |
|
|
2019
Q3 | $17.7M | Sell |
184,603
-29,575
| -14% | -$3.3M | 0.03% | 397 |
|
|
2019
Q2 | $24.7M | Sell |
214,178
-34,521
| -14% | -$4.13M | 0.04% | 344 |
|
|
2019
Q1 | $29.3M | Buy |
248,699
+121,912
| +96% | +$10.7M | 0.05% | 317 |
|
|
2018
Q4 | $7.94M | Buy |
126,787
+13,669
| +12% | +$859K | 0.01% | 462 |
|
|
2018
Q3 | $8.02M | Buy |
113,118
+78,474
| +227% | +$5.4M | 0.01% | 508 |
|
|
2018
Q2 | $2.31M | Buy |
+34,644
| New | +$2.28M | ﹤0.01% | 595 |
|
Other funds holding ASND
RCM
ACA
